L-Tyrosine

Not a “traditional herb.” Tyrosine’s clinical/nutritional uses arise from its role as a biochemical precursor (see below). Clinically, supplemental tyrosine has been used experimentally to support cognitive performance under acute stress, and nutritionally to supply patients (e.g., with PKU) who cannot synthesize tyrosine from phenylalanine.

1. Chemical formula: C9H11NO3

• Molecular weight: 181.19 g·mol⁻¹ Structure: amino acid with a hydroxy-phenyl side chain (para-hydroxy). Forms: L-isomer (physiologically active) available as powder, capsules, tablets.

1.Pharmacological Properties (mechanisms)

• Precursor to catecholamines L-tyrosine → L-DOPA → dopamine → norepinephrine → epinephrine. Supplementation can increase brain tyrosine availability and support catecholamine synthesis when precursors or neurotransmitter stores are depleted (e.g., during acute stress, prolonged cognitive load, sleep deprivation). Precursor to thyroid hormones tyrosine is a building block for thyroxine (T4) and triiodothyronine (T3) via iodinated tyrosine residues in the thyroid gland; hence it has an indirect link to thyroid function. DrugBank

Protein synthesis & melanin incorporated into proteins and is the precursor for melanin (via tyrosinase).

1. Short summary (executive):

• Best evidence supports use of oral L-tyrosine to improve cognitive performance, alertness, and working memory under acute stressors (sleep deprivation, cold, multi-tasking, high-workload). Evidence for long-term mood improvement, depression, or ADHD is limited/mixed. Tyrosine is also nutritionally essential (supplemental) for people with phenylketonuria (PKU) because they cannot convert phenylalanine to tyrosine.

2. Detailed evidence (selected, high-value findings):

• Cognitive performance under acute stress / sleep deprivation / demanding tasks Multiple RCTs and reviews show consistent short-term benefits: improved vigilance, working memory, reaction time and reduced performance decline during cold exposure, prolonged work, or sleep loss when tyrosine is given acutely before or during the stressor. (Key reviews: Jongkees 2015; Bloemendaal et al. 2018). Typical experimental acute doses range from moderate single grams to weight-adjusted dosing (see Dosage).

Example trials: Neri et al. (1995) and Deijen et al. (1999) found improved psychomotor performance and reduced cognitive decline in stressful task paradigms after tyrosine.

3. Military / occupational performance contexts:

• A systematic review suggested tyrosine (and caffeine) could be considered to improve performance in sleep-restricted, high-stress environments (e.g., military operations). Evidence supports short-term use under strictly defined conditions.

4. Phenylketonuria (PKU):

• In PKU (where phenylalanine hydroxylase is deficient), tyrosine becomes conditionally essential. Medical guidance supports dietary/medical management to ensure adequate tyrosine intake; however, routine high-dose supplemental tyrosine beyond standard dietary management is not universally endorsed without specialist input.

5. Mood / depression / ADHD / other psychiatric uses:

• Evidence is mixed and insufficient for routine use as an antidepressant or ADHD treatment. Some older studies explored antidepressant augmentation but results are inconsistent. Tyrosine may transiently affect mood via catecholamines in acute depletion states but is not a proven primary treatment for depression or ADHD.

6. Physical performance and exercise:

• Limited evidence; some small studies suggest tyrosine may help cognitive aspects of performance (reaction time, decision making) during prolonged exercise or heat/cold stress, but effects on strength or endurance are minimal/uncertain.

• Phenylketonuria (PKU) management nuance: people with PKU require specialist dietary management; tyrosine is necessary but dosing must be managed by metabolic specialists.
• Severe hyperthyroidism or active thyroid cancer: because tyrosine is a precursor to thyroid hormones, exercise medical caution with thyroid disease and thyroid hormone therapy (discuss with endocrinologist). Known allergy to formulation components (rare).
• Pediatric use: for infants/children, use only under clinical direction (PKU exceptions aside)

• Common / mild: gastrointestinal upset (nausea), headache, heartburn/acid reflux, fatigue or restlessness in some individuals. Most studies report good tolerability at typical supplement doses (≤2 g/day).
• At high doses / rare: possible changes in blood pressure (via catecholamine changes), overstimulation, or sleep disturbance in sensitive people. There are case reports and theoretical concerns about interactions (see Drug Interactions). Overall adverse event incidence in clinical trials is low

High-priority interactions to watch for (documented or mechanistically plausible):

• Levodopa (L-DOPA) tyrosine and levodopa may compete for intestinal absorption and CNS transport; tyrosine might reduce levodopa efficacy if taken together and may increase levodopa excretion in some contexts. Clinically, separate dosing and consult neurology/clinical pharmacology when combining.
• Monoamine oxidase inhibitors (MAOIs) because tyrosine can increase catecholamine synthesis, combining with MAOIs might theoretically increase risk of hypertensive episodes or other catecholaminergic effects. Avoid combining without close medical supervision. (General prescribing cautions are advised.)
• Thyroid hormone replacement tyrosine is a precursor for thyroid hormones; while direct antagonistic interactions are uncommon, people on levothyroxine or antithyroid therapies should discuss supplementation with their clinician.
• Drugs affected by catecholamine levels (some stimulants, sympathomimetics, certain antihypertensives) additive or opposing effects are possible; monitor clinically.
• Herbs/adaptogens combination with other stimulatory supplements (e.g., high-dose caffeine, synephrine, ephedra-like agents) may amplify sympathomimetic effects; cautious co-use recommended. Evidence on specific herb-tyrosine interactions is sparse; apply standard herb–drug caution.

Practical advice: always review concurrent prescriptions (especially levodopa, MAOIs, stimulants, and thyroid meds) with a clinician or pharmacist before starting tyrosine.

1. Stress: https://pubmed.ncbi.nlm.nih.gov/26424423/
2. Cognitive Performance: https://www.sciencedirect.com/science/article/abs/pii/S0361923098001634?
3. Thyroid: https://pmc.ncbi.nlm.nih.gov/articles/PMC4308793/#abstract1 https://go.drugbank.com/drugs

When it helps: L-tyrosine is best supported as a short-term, acute cognitive enhancer to reduce performance decline in stressful or sleep-deprived situations; evidence is robust enough for consideration in occupational/military contexts. When to be cautious: avoid unsupervised high single doses (many grams) outside research; consult before combining with levodopa, MAOIs, thyroid medications, or potent stimulants. People with PKU need specialist dietary care. Practical dosing: typical supplement users take 500–2,000 mg/day; research contexts use higher weight-adjusted acute doses (e.g., up to 100–150 mg/kg in single doses for experimental paradigms). Use lower daily doses for safety and clinician oversight.